INTRODUCTION
PRL is unique among the pituitary hormones in that it is primarily under inhibitory control. In the absence of tonic inhibition from the hypothalamus, PRL is produced and secreted at a high basal rate (1) . PRL is also produced at a high basal rate in various pituitary tumor cell lines {e.g. GH 3 and GH4CO (2) . This high basal rate of PRL gene expression is dependent on calcium in both GH 3 cells (3) and primary pituitary cultures (4) . Studies have indicated that Ca 2+ stimulates PRL gene expression at both transcriptional (5-7) and posttranscriptional levels (7) .
In addition to the Ca
2+
-dependent enhancement of basal PRL gene expression, the PRL gene is regulated by several hormones, neurotransmitters, and growth factors. The primary inhibitor of PRL production in vivo is dopamine (1) . Somatostatin and glucocorticoids also inhibit PRL gene expression (8) (9) (10) . In addition, there are a number of factors capable of stimulating PRL synthesis and release, including TRH (11), vasoactive intestinal peptide (12) , and estrogen (10, 13, 14) . Serum augments PRL production in cultured pituitary cells, and at least part of this stimulation is due to growth factors. Among these are fibroblast growth factor and epidermal growth factor (EGF), which are found in the pituitary (15, 16) . Both EGF and fibroblast growth factor stimulate PRL gene expression (17, 18) . Transforming growth factor-a (TGFa), which is structurally related to EGF and binds to the same receptor, is also produced by lactotrophs (19) and stimulates PRL production (20) .
In studying the regulation of several aspects of GH 3 cell function by serum factors, we examined the effects of another growth factor, TGF/?, on PRL mRNA levels. TGF/? is a member of a large family of growth factors with wide-ranging effects, including pituitary hormone regulation (for reviews, see Refs. 21 and 22) . There are three forms of TGF/? found in mammals as well as a fourth in the chicken (23) and a fifth in Xenopus (24) . TGF0 has broad effects on cell growth and extracellular matrix deposition, and appears to be very important for the differentiation of some tissues during development (21, 22) . Other members of this family are the developmental regulators Mullerian inhibiting substance (25) , bone morphogenetic proteins (26) , Xenopus mesoderminducing factor (27) , and the Drosophila homeotic gene product decapentaplegic (28) . A third subset of the TGF/? family includes the inhibins and activins (29) , which are gonadal regulators of pituitary function. Inhibins and activins inhibit or stimulate, respectively, the production of FSH by gonadotrophs without affecting LH. Activin is also able to inhibit secretion of GH and ACTH by primary cultures of pituitary cells, an effect that is antagonized by inhibin (30) . TGF/3 inhibits the ability of cultured fibroblasts to express the mRNA for mitogen-regulated protein/proliferin (31) . Mitogen-regulated protein/proliferin is a member of the PRL/GH/placental lactogen gene family with considerable structural similarity to PRL (32, 33) . Receptors that bind several members of the TGF0 family have been detected on GH 3 cells (34). Ramsdell (20) recently reported that TGF/3 inhibited proliferation of GH 4 pituitary cells, and that TGF/3 and activin decreased PRL production. We now report that TGFj3 is a specific and potent inhibitor of both basal and Ca 
RESULTS

TGF0 Inhibits PRL Gene Expression
PRL mRNA declines to low levels in GH 3 cells cultured in serum-free medium (SFM) for 24 h. As shown previously (3,7), addition of 0.5 ITIM CaCI 2 to SFM specifically increased PRL mRNA by several-fold (Fig. 1A) . The addition of 10 ng/ml of either TGF/31 or TGF/32 to GH 3 cell cultures reduced basal PRL expression in SFM by 40% and almost completely inhibited the ability of Ca 2+ to increase PRL mRNA levels (TGF/31, 76% inhibition; TGF/32, 72% inhibition). The effects of TGF/31 and TGF/32 were specific for PRL, as there was no change in the mRNA levels of GH (Fig. 1A) . TGF/3 treatment also lowered basal PRL mRNA levels by 35% in cells cultured in normal serum-supplemented growth medium (Fig. 1B ). This extent of inhibition was the same as that in cells cultured SFM plus Ca 2+ (Fig. 1B) , even though growth cultures contained less PRL mRNA than Ca 2+ -treated cells. Treatment of GH 3 cells with doses of TGFj31 ranging from 0.1-10 ng/ml (4-400 PM; Fig. 1C ) showed that TGF|8 is a potent inhibitor of PRL mRNA expression. Inhibition was first detectable at 0.5 ng/ml and is nearly complete at 10 ng/ml. There was no effect of TGF/3 on the expression of GH, Pit-1 (see below), histone-3, or glucose-regulated protein 78 (GRP78) mRNAs over a dose range of 0.02-10 ng/ml (data not shown). The responsiveness of an independently derived pituitary tumor cell line, 235-1 cells, to TGF/3 was also examined. The 235-1 cells display high levels of PRL production, but have been shown to be unresponsive to TRH and estrogen (35) . In two separate experiments, TGF/3 had no effect on PRL mRNA levels in 235-1 cells (data not shown).
To determine whether TGFjS inhibited PRL gene expression in GH 3 cells at the transcriptional level, runon transcription assays were performed using nuclei from cells that were either untreated (SFM control) or levels by TGF/3. GH 3 cells were treated with 0.5 mM Ca 2+ in the presence of increasing doses of TGF/3, from 0.1-10.0 ng/ ml (4-400 PM). Values are expressed as the fold induction over the SFM control and are the average ± range of duplicate dots from duplicate cultures.
treated for 20 h with Ca 2+ or Ca 2+ plus 5 ng/ml TGF/3. Cytoplasmic RNA was isolated from the cells in each treatment group at the time of nuclear isolation, and PRL, GH, Pit-1, and GRP78 mRNA levels were analyzed by Northern blot hybridization. Two separate experiments produced similar results; the results of one experiment are shown in Fig. 2 . As a control for inhibition of PRL gene transcription, cells were also treated with Ca 2+ plus 100 nM dexamethasone (Dex) (9, 10). As expected, Dex decreased PRL gene transcription to 0.6-fold of that in the SFM control and reduced PRL mRNA levels by about 80%. Dex also induced a small increase in the levels of GH mRNA, as previously described (36) .
PRL gene transcription in Ca 2+ -treated cells was 1.3-fold of that in SFM controls (Fig. 2, A and C) . In contrast to this small change in PRL gene transcription and consistent with previous findings (7), Ca 2+ induced a 7.0-fold increase in the steady state levels of PRL mRNA ( Fig. 2B and C) . TGF/3 reduced Ca 2+ -stimulated PRL gene transcription by 50%, to a level 0.7-fold of that in the serum-free control, and inhibited the Ca 2+ -induced increase in PRL mRNA levels by 64%. Again, the effect of TGF/? was specific for PRL, as mRNA levels for GH, Pit-1 (see below also), and GRP78 were not significantly changed by TGF/3.
Nuclear RNA isolated from GH 3 cells treated with Ca 2+ for 24 h in the presence or absence of 5 ng/ml TGF/3 was subjected to Northern blot analysis. In support of a transcriptional effect of TGF/3, there was a proportional decrease in both the mature PRL mRNA and nuclear PRL mRNA precursors in RNA from TGF/3-treated cells (Fig. 2D) .
Time-course studies indicate that a decrease in PRL mRNA levels can be observed as soon as 3-6 h (Fig.  3 ) after the addition of TGF/3 to culture medium. Inhibition was maximal at 12-24 h. Since widely divergent values have been reported for PRL mRNA stability (7, 37) , it is difficult to state whether this relatively rapid decrease in PRL mRNA is due solely to transcriptional repression or to an additional destabilizing effect of TGFjS on PRL mRNA. Although we have not performed a detailed time-course study on the transcriptional effects of TGF/3, we have observed a 35% decrease in PRL gene transcription 6 h after TGF/3 treatment (data not shown).
TGF/3 Does not Affect Pit-1 Gene Expression
One mechanism by which TGF/3 might inhibit PRL gene transcription is via inhibition of Pit-1 gene expression. Pit-1 is a pituitary-specific transcription factor regulating the expression of PRL and GH genes (38, 39) . In a separate experiment, we compared the effects of TGF/3 on PRL mRNA and Pit-1. As shown in Fig. 4A , Ca 2+ increased PRL mRNA by about 2-fold over that in SFM controls after 24 h. TGF/3 completely blunted this effect of Ca 2+ . In contrast, the presence of Ca 2+ or Ca 2+ plus TGF/3 had no effect on Pit-1 mRNA. These findings are supported by the Northern hybridization data shown in Fig. 2B . In this experiment, the presence of Ca 2+ lowered Pit-1 mRNA levels, although correction for loading/ transfer based on GRP78 mRNA levels indicate that the effect of Ca 2+ on Pit-1 mRNA is slight. More importantly, TGF/3 had no effect on Pit-1 mRNA levels. Additionally, the effect of TGF/3 on Pit-1 gene transcription was assessed by run-on assay, using labeled RNAs from the experiment shown in Fig. 2 . While TGF/3 decreased PRL gene transcription by about 50% (Fig.  2, A and C) , it had no effect on Pit-1 gene transcription (Fig. 4B) . Pit-1 gene transcription approximately doubled in the presence of Ca 2+ , regardless of other treatments.
DISCUSSION
Our data demonstrate that TGF/3 is a potent and specific inhibitor of both basal and Ca 2+ -stimulated PRL mRNA expression in GH 3 cells. The inhibitory effect of TGFjS occurred without changes in the expression of several constitutively expressed genes (histone-3 and GRP78) or in the levels of GH and Pit-1 mRNAs. Ramsdell (20) has also reported that TGF/3 and activin inhibit PRL production by GH 4 cells. This implies that inhibition of PRL gene expression is a physiological effect of TGF/3 or a closely related factor. The results of run-on transcription assays were striking, in that Ca 2+ increased PRL gene transcription by only 30%, yet it induced a 7-fold increase in PRL mRNA levels. This confirms our previous findings (7) and supports the idea that Ca 2+ induction of PRL gene expres-sion has a substantial posttranscriptional component. The inhibition of PRL gene expression by TGF/3, on the other hand, appears to occur mainly at the transcriptional level. PRL gene transcription and mRNA levels decreased 50-60% in TGF/3-treated cells. Additionally, nuclear PRL precursor RNAs in TGF/3-treated cells decreased proportionately with the mature PRL mRNA.
Our data indicate that TGF/3 does not act on PRL gene expression via an inhibition of Pit-1 gene expression. These data do not address the possibility of TGF/3-induced posttranslational modifications of the Pit-1 protein. Alternatively, Kerr et al. (40) provided evidence that TGF/3 inhibits transin/stromelysin gene transcription through a TGF/3 inhibitory element (TIE), GAGTTGGTGA. This element acts as an AP-1 site, and activation of c-fos is required for TGF0 repression of transin/stromelysin gene transcription (40) . These researchers also noted that apparent TIEs with the consensus sequence GnnTTGGtGa reside within the promoters of the other TGF/3-inhibited genes, including proliferin. Although the activities of these TIEs have yet to be determined, it is interesting to note that two putative TIEs reside within the rat PRL gene promoter. These are GAATTGGGGA at position -1016 and GCTTTGGGGT at position -1561 relative to the transcription start site. We have observed an increase in cfos mRNA in response to TGF/3 in GH 3 cells (our unpublished observations). However, since c-fos mRNA is also readily detectable in GH 3 cells cultured in SFM plus Ca 2+ (our unpublished observations), and since cfos mRNA is increased in GH 3 cells by other treatments that are associated with an increase in PRL mRNA (41) , any contribution of c-fos to the effect of TGF0 is likely to be a complex one. The AP-1 family represents a large number of proteins, of which some are stimulatory and some inhibitory at AP-1 sites (42). Thus, it is possible that another AP-1 protein gene is induced by TGF/3 which heterodimerizes with c-fos to inhibit the expression of specific genes. Further experiments are needed to examine whether c-fos is required for the effects of TGF/3 on PRL gene transcription and whether the putative TIEs within the PRL promoter confer transcriptional repression by TGF/3.
The potency and specificity of the inhibition of PRL gene expression by TGF/3 in our studies and those of Ramsdell (20) suggest that there may be a physiological role for TGF/3 in regulation of lactotroph function. Expression of the PRL and GH genes is dependent on the presence of Pit-1/GHF-1 (38, 39, 43) . However, the heterogeneity of PRL-producing cells in the pituitary (44) and in tumor lines (45) makes it likely that the specification of cell type also requires additional factors. It is possible that factors, such as TGF/3, that regulate both PRL gene expression and lactotroph proliferation may be involved in this specification of pituitary cell phenotype.
MATERIALS AND METHODS
Cell Culture
GH 3 cells were obtained from the American Type Culture Collection (Rockville, MD) and maintained in suspension culture (46) . The 235-1 cells were generously provided by Dr. H. Samuels (New York University School of Medicine) and maintained in Spinner culture medium (46) containing 10% ironsupplemented calf serum (Hyclone, Logan, UT). For experiments, cells were spun out of growth medium, washed once in SFM (46) , and plated onto 35-or 60-mm tissue culture dishes (Falcon, Oxnard, CA). Treatments were added at the time of plating, and the cells were cultured for 18-24 h, as indicated, in a 37 C humidified incubator at 2% CO 2 .
TGF/3 and Dex
Porcine TGF/31 and TGF02 (R & D Systems, Minneapolis, MN) or human TGF/31 (Collaborative Research, Bedford, MA) were resuspended at a concentration of 2 ng/ml in sterile diluent (4 mM HCI and 1 mg/ml BSA) and added to GH 3 cell cultures at final concentrations ranging from 0.02-10 ng/ml. Diluent alone had no effect on any of the mRNAs measured. Dex (Sigma, St. Louis, MO) was dissolved in PBS at 50 mM and used at a final concentration of 100 nM. ), Ca 2+ plus 5 ng/ml TGF/3, or Ca 2+ plus 100 nM Dex. Cells were collected by scraping, pooled, and washed once in ice-cold PBS, and then nuclei were isolated and used for run-on transcription, as previously described (7), using 300 mCi [ M NaOH and incubation on ice for 15 min, and then neutralized by the addition of 100 ^l 1 M HEPES-free acid plus 650 n\ TES buffer. The total counts per min of 32 P-labeled RNA in 5 n\ of each sample were determined, and equal counts per min in 1 ml TES buffer were added to 1 ml TES buffer plus 0.6 M NaCI, then hybridized to DNA dots on nitrocellulose filters that were prehybridized as previously described (7) . DNA dots were made with linearized and denatured plasmids containing either no insert (Bluescript KS+), a PRL cDNA clone (PRL-SK + ; see below), or a plasmid containing a Pit-1 cDNA (see below). Hybridization was carried out at 52 C for 2 days. Filters were washed twice in 2 x SSC (0.3 M NaCI and 0.03 M sodium citrate, pH 7) for 1 h at 65 C, then treated with 1 mg/ ml RNase-A (Boehringer Mannheim, Indianapolis, IN) in 2 x SSC for 30 min at 37 C. After a final wash in 2 x SSC at 37 C for 1 h, filters were blotted dry and analyzed using a Betascope 603 blot analyzer (Betagen, Waltham, MA).
Run-On Transcription Assay
RNA Isolation and Analysis
Cytoplasmic RNA was prepared from cell lysates after removal of nuclei by centrifugation. Cytoplasmic lysates (5 ml) were combined with an equal volume of 2 x proteinase-K buffer [2 x = 0.2 M Tris-CI (pH 7.5), 0.44 M NaCI, 2% sodium dodecyl sulfate, and 25 mM EDTA] plus 200 Mg/ml proteinase-K and incubated for 30 min at 37 C. The samples were extracted once with phenol-chloroform (1:1), twice with chloroform, and then made 0.25 M in NaCI and ethanol precipitated. Tenmicrogram aliquots of RNA were electrophoresed on 1 % agarose-formaldehyde gels and analyzed by Northern blot hybridization (48) .
Nuclear RNA was isolated from GH 3 cells (five 100-mm dishes per group) that were cultured in SFM plus Ca 2+ in the presence and absence of 5 ng/ml TGF/3 for 24 h. Cells were collected by scraping, pooled, washed once in ice-cold PBS, and then resuspended in 1.8 ml PBS. Cells were lysed by the Downloaded from https://academic.oup.com/mend/article-abstract/5/11/1716/2714280 by guest on 22 November 2018 TGF/3 Inhibits PRL Gene Transcription addition of 0.2 ml Nonidet P-40 (5% in PBS), incubated on ice for 3 min, then centrifuged at 1000 x g for 5 min at 4 C. Supernatants were used for preparation of cytoplasmic RNA, as described above. The nuclear RNA was isolated essentially as previously described (49) . Ten-microgram aliquots of nuclear RNA were electrophoresed through 1 % agarose-formaldehyde gels, then transferred to nitrocellulose for Northern blot hybridization analysis.
RNA was also measured by cytoplasmic dot hybridization, as previously described (50) . The PRL, GH, GRP78, and histone-3 DNA probes used in this study have been previously described (7) , except that the PRL cDNA used in this study was the insert from pPRL-1 (7), which was reinserted into the Pst\ site of the Bluescript SK + vector (Stratagene, La Jolla, CA). The PRL probe used for Northern blot hybridization analysis of nuclear RNA was generated by polymerase chain reaction using oligonucleotide primers to exons 1 and 5 of the rat PRL cDNA. The Pit-1 cDNA probe (39) was generously provided by Drs. H. Ingraham and M. G. Rosenfeld (University of California-San Diego).
